TORONTO (AP) — TORONTO (AP) — Aeterna Zentaris Inc. (AEZS) on Thursday reported a loss of $12.5 million in its fourth quarter.
The Toronto-based company said it had a loss of $2.56 per share. Losses, adjusted for asset impairment costs, were 84 cents per share.
The drug developer posted revenue of $2.5 million in the period.
For the year, the company reported that its loss widened to $22.7 million, or $4.68 per share. Revenue was reported as $5.6 million.
The company's shares closed at $2.65. A year ago, they were trading at $8.90.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AEZS at https://www.zacks.com/ap/AEZS